Signal integration by JNK and p38 MAPK pathways in cancer development

EF Wagner, ÁR Nebreda - Nature Reviews Cancer, 2009 - nature.com
Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) family
members function in a cell context-specific and cell type-specific manner to integrate signals …

A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches

E Seki, DA Brenner, M Karin - Gastroenterology, 2012 - Elsevier
c-Jun-N-terminal kinase (JNK) is a mitogen-activated protein kinase family member that is
activated by diverse stimuli, including cytokines (such as tumor necrosis factor and …

Selective inhibitors for JNK signalling: a potential targeted therapy in cancer

Q Wu, W Wu, V Jacevic, TCC Franca… - Journal of enzyme …, 2020 - Taylor & Francis
Abstract c-Jun N-terminal kinase (JNK) signalling regulates both cancer cell apoptosis and
survival. Emerging evidence show that JNK promoted tumour progression is involved in …

JNK signalling in cancer: in need of new, smarter therapeutic targets

C Bubici, S Papa - British journal of pharmacology, 2014 - Wiley Online Library
The JNKs are master protein kinases that regulate many physiological processes, including
inflammatory responses, morphogenesis, cell proliferation, differentiation, survival and …

Discovery of potent and selective covalent inhibitors of JNK

T Zhang, F Inesta-Vaquera, M Niepel, J Zhang… - Chemistry & biology, 2012 - cell.com
The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that
transduce and integrate extracellular stimuli into coordinated cellular response. Here, we …

Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation

JF Tanti, J Jager - Current opinion in pharmacology, 2009 - Elsevier
Insulin receptor substrates (IRS) serine phosphorylation is a time-controlled physiological
feedback mechanism in insulin signaling that is hijacked by metabolic and inflammatory …

Targeting p38 MAPK pathway for the treatment of Alzheimer's disease

L Munoz, AJ Ammit - Neuropharmacology, 2010 - Elsevier
Accumulating evidence indicates that p38 mitogen-activated protein kinase (MAPK) could
play more than one role in Alzheimer's disease (AD) pathophysiology and that patients …

JNK pathway signaling: a novel and smarter therapeutic target for various biological diseases

A Kumar, UK Singh, SG Kini, V Garg… - Future medicinal …, 2015 - Taylor & Francis
JNK pathway regulates various physiological processes including inflammatory responses,
cell differentiation, cell proliferation, cell death, cell survival and expression of proteins …

c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges

MA Bogoyevitch, KRW Ngoei, TT Zhao… - … et Biophysica Acta (BBA …, 2010 - Elsevier
c-Jun N-terminal kinases (JNKs), first characterized as stress-activated members of the
mitogen-activated protein kinase (MAPK) family, have become a focus of inhibitor screening …

Targeting innate immunity protein kinase signalling in inflammation

M Gaestel, A Kotlyarov, M Kracht - Nature Reviews Drug Discovery, 2009 - nature.com
Inflammation is an evolutionarily conserved host reaction that is initiated in response to
trauma, tissue damage and infection. It leads to changes in tissue homeostasis and blood …